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Background: Cell migration plays a major role in a variety of normal biological processes, and a detailed understanding
of the associated mechanisms should lead to advances in the medical sciences in areas such as cancer therapy.
Previously, we developed a simple chip, based on transfected-cell microarray (TCM) technology, for the identification of
genes related to cell migration. In the present study, we used the TCM chip for high-throughput screening (HTS) of a
kinome siRNA library to identify genes involved in the motility of highly invasive NBT-L2b cells.
Results: We performed HTS using TCM coupled with a programmed image tracer to capture time-lapse fluorescence
images of siRNA-transfected cells and calculated speeds of cell movement. This first screening allowed us to identify 52
genes. After quantitative PCR (qPCR) and a second screening by a conventional transfection method, we confirmed that
32 of these genes were associated with the migration of NBT-L2b cells. We investigated the subcellular localization of
proteins and levels of expression of these 32 genes, and then we used our results and databases of protein-protein
interactions (PPIs) to construct a hypothetic but comprehensive signal network for cell migration.
Conclusions: The genes that we identified belonged to several functional categories, and our pathway analysis
suggested that some of the encoded proteins functioned as the hubs of networks required for cell migration. Our
signal pathways suggest that epidermal growth factor receptor (EGFR) is an upstream regulator in the network, while
Src and GRB2 seem to represent nodes for control of respective the downstream proteins that are required to
coordinate the many cellular events that are involved in migration. Our microarray appears to be a useful tool for the
analysis of protein networks and signal pathways related to cancer metastasis.Background
Cell migration is necessary for many physiological
processes, such as tissue development, wound healing,
and inflammation, as well as for pathological processes
such as the metastasis of cancer cells [1]. Cell migration
involves regulation of the cytoskeleton, substrate adhesion,
membrane trafficking, and cell polarity. As a consequence,
the regulation of cell migration is complex [2], requiring
coordinated spatiotemporal control of such cellular events
during the migration process. An understanding of the
relationships of these phenomena to cell migration is
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article, unless otherwise stated.such as cancer therapy. Wound-healing and Boyden
chamber assays have been used in attempts to unravel the
molecular mechanisms of cell migration, and they have
provided information about some aspects of cell migration
[3,4]. However, the molecular basis for the cooperativity
between these events in migrating cells remains unclear.
Thus, complete identification of all genes involved in cell
migration is needed.
We developed a simple cell microarray chip for
high-throughput phenotypic screening (HTS) that
could be used to identify genes that are required for cell
migration [5,6]. Our chip is based on the transfected cell
microarray (TCM) technology [7]. Microarray spots,
including plasmid DNA, siRNA, and transfection reagents,
are printed on a glass slide that has been coated with type I
collagen. Cells take up DNA and siRNAs from the spots,Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Our methodology has advantages over earlier methods,
such as the wound-healing and Boyden chamber assays, in
that (i) it can be used for efficient HTS of siRNAs
and cDNAs and (ii) it excludes the possibility of contact
inhibition and the release of inflammatory cytokines from
wounded cells.
In a previous study, we performed a model screening
using siRNAs directed against known motility-related
genes to validate our methodology. In the present study,
we preformed HTS and identified genes related to cell
migration using our cell chip on which a kinome siRNA
library had been spotted. Cell migration is a highly inte-
grated and multistep process. Therefore, migration speeds
should change when the function of any gene involved
in any of the steps is impeded. We postulated that
our approach would allow us to identify previously
unrecognized genes involved in cell migration and to
characterize the mechanisms that control cell migration.
Results
Screening for genes that regulate cell migration
using TCM
Some kinases have been shown to be potential or even
actual targets for anti-cancer drugs because such drugs
function by altering signal transduction and changing
the properties of cancer cells (http://www.cancer.gov/
drugdictionary). Among available anti-cancer drugs di-
rected against molecular targets, more than half target
kinases. Therefore, we decided to search for kinases that
regulate cell migration using a kinome siRNA library
printed on a TCM chip. We used the commercially avail-
able Rat Kinase siRNA Set Version 1.0 from QIAGEN
(Tokyo, Japan), which consists of siRNAs that target two
different sites in each of 738 genes for kinases and related
proteins without kinase activity, such as activators and
inhibitors of kinases. On each glass slide, we printed
four copies of ten different transfection mixtures,
each containing siRNA as shown in Additional file 1.
As in our earlier study, anti-paxillin (Pxn) and non-targeted
siRNAs were printed on each slide as a positive and a
negative control, respectively. To screen for genes
required for cell migration, we produced 148 TCM
chips with “4 × 12” grids (48 spots/chip). We used a
line of NBT-L2b cells that is a subpopulation of cells
isolated from parent NBT-II cells derived from a rat
bladder carcinoma [8] because of their rapid (2 μm/min)
and unidirectional movement on type I collagen-coated
substrates [5]. When cells grow to a high density during
experimental observations, it is hard to evaluate their
migration on the small regions on a cell chip. The rapid
migration of cells is, therefore, very important for success-
ful screening on a cell chip because analysis can be com-
pleted before cell density becomes a problem. Suspensionsof NBT-L2b cells were seeded onto the slides and incu-
bated at 37°C (Additional file 1). After 24 h, fluorescent
images of individual cells were captured for a 3-h period
at 10-min intervals, and speeds of cell migration were
calculated with Image J software and manual tracking
plug-in (URL: http://rsb.info.nih.gov/ij/). We compared
the mean speeds of individual cells that had been trans-
fected with a target siRNA, a control siRNA [non-target
(NT) siRNA or anti-Pxn siRNA] using the Mann-Whitney
U-test. We identified 53 siRNAs, targeted to 52 genes, for
which this comparison gave a P-value of less than 0.1
(Table 1 and Additional file 2).
Of the 51 siRNAs that decreased the mean speed of
migration of individual cells, as compared with the NT
control siRNA, 40 siRNAs were more inhibitory with the
anti-Pxn control siRNA. Two siRNAs (indicated Ilk and
Zfp512b in Table 1) increased the speed of migration as
compared to the effect of the NT siRNA.
Second screening with a sensitive assay of motility
For a more accurate evaluation of cell migration in a
second screening, we modified the screening method as
follows. Fibronectin, one of the components of the
transfection mixture, is essential for efficient transfection
on cell chips, but NBT-II cells [9] and the derivative
NBT-L2b cells [5] migrate more slowly on fibronectin
than on collagen. Slower migration on a spot on the chip
might, therefore, affect the accurate evaluation of cell
speed. In addition, the fluorescence excitation required
for visualization of cells might be toxic to migrating cells.
Therefore, to evaluate the genes identified in the first
screening in the absence of such potential confounding
factors and for more accurate screening, we performed a
second screening without exposure of cells to excitation
light and, also, using a conventional method for transfec-
tion. After such transfection, cells were cultured for 38 h
and transferred from 6-well microtiter plates to collagen-
coated 24-well microtiter plates. Time-lapse imaging was
initiated 6 h after the transfer of cells to the 24-well plates,
because we had found that the migration speed is maximal
at that time (data not shown). Knockdown of gene expres-
sion by siRNA is usually observed 24 to 48 h after trans-
fection. After capturing a single fluorescent image for
identification of transfected cells, we monitored cells by
recording phase-contrast images at 5-min intervals for
6 h. In the second screening, we focused on the 51 siRNAs
that had been found to have on inhibitory effect on cell
migration plus the two siRNAs that accelerated migration.
The second screening identified 30 siRNAs that
targeted 30 genes and suppressed cell migration, with
P-values below 0.05 by the Mann-Whitney U-test
(Figure 1A). We also confirmed that two siRNAs,
namely, anti-Ilk and anti-Zfp512b, had accelerative
effects (Figure 1B). The knockdown efficacy of the
Table 1 Results of the first screening
Genea Alias Control P valueb
Vapa Pxn 6.69E-13









Mapk8ip JIP1 Pxn 6.26E-05
Map4k4 Pxn 2.00E-04
Mapk8ip3 JSAP1 Pxn 3.82E-04
Irak1bp1 Pxn 5.03E-04
Riok3 Pxn 7.00E-04
Trib3 NIPK Pxn 1.40E-03
Prkca Pkca Pxn 2.60E-03
Srpk1 Pxn 2.90E-03
Cdk13 Cdc2l5 Pxn 4.00E-03
Bmpr1a Pxn 4.00E-03






Camk2b Ck2b Pxn 8.90E-03
Zap70 Srk Pxn 1.10E-02
Camkv 1G5 Pxn 1.20E-02
Tgfbr1 Pxn 1.80E-02
Ksr1 Ksr Pxn 2.10E-02





Chka Chk Pxn 5.70E-02
Pik3ca Pxn 8.90E-02
Flt3 Pxn 9.00E-02
Mob3c Mobkl2c Pxn 9.80E-02
Dstyk Ripk5 NT 4.27E-06
Map2k6 Mkk6 NT 7.48E-06
Dapk1 NT 9.12E-06
Prps2 NT 1.85E-04





Dgkg Dagk3 NT 6.50E-02
Ckmt1b Ckmt1 NT 8.69E-02
Nek4 NT 9.97E-02
Zfp512bc Urkl1 NT 1.20E-02
Ilkc NT 8.30E-02
aThe mean speeds of individual cells that expressed a test or control siRNA
[non-target (NT) siRNA or anti-paxillin (Pxn) siRNA] were compared using the
Mann-Whitney U-test (P < 0.1, control versus each siRNA). Fifty-one
siRNAs, corresponding to 50 genes, had inhibitory effects on cell migration. bThe
associated P-values are also shown. c The siRNAs that facilitated migration.
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anti-Ksr siRNAs, ranged from 20% to 70% (Figure 2). A
statistical analysis of the effect of anti-Btk, anti-Cdk13,
anti-Flt3, anti-Prkd1 and anti-Vapa siRNAs indicated that
the knockdown effect was not statistically significant. The
apparently positive results were caused, most likely, by
low-level gene expression or weak amplification by PCR.
Although the mean levels of expression (n = 4) of the
Chka and Ksr genes were depressed to a relatively minor
extent by the corresponding siRNAs, the inhibitory effects
of these siRNAs on motility were highly reproducible. We
decided, therefore, to use all the selected genes, including
Chka and Ksr, in our subsequent analysis. In addition, we
used anti-Pxn siRNA as a positive control, as described
previously [5].
Subcellular localization of products of the newly
identified genes
As described above, the 30 genes selected in the second
screening had the apparent potential to accelerate
and/or support the migration of NBT-L2b cells. In
addition, the Ilk and Zfp512b genes had a potentially
suppressive effect on cell migration. To investigate
the localization of the proteins encoded by these genes in
migrating NBT-L2b cells, we amplified the corresponding
cDNAs from cDNA libraries. Each amplified full-length
cDNA was cloned into the pEGFP vector for expression
as a fusion protein with enhanced green fluorescent
protein (EGFP). We failed to obtain full-length cDNAs for
the Btk, Camk2b, Flt3, Prkd1, Zfp512b, and Zap70
genes from cDNA libraries that had been prepared
from NBT-L2b cells, presumably because of low levels
of expression or incorrect DNA sequence information.
However, we were able to amplify the six cDNAs from a
human cDNA library. Expression plasmids encoding
EGFP fusion proteins were introduced individually into
NBT-L2b cells by transfection and transformants were
Figure 1 The effects of siRNAs on cell migration. The siRNAs identified in the first screening (black bars), non-target siRNA as a negative control (NT,
dark gray bars), anti-paxillin siRNA as a positive control (Pxn, light gray bars) and the pVenus-N1 vector were introduced into NBT-L2b cells by conventional
transfection. The migration speed of individual cells (N > 50) was analyzed by the ImageJ software with a manual tracking plug-in. The speeds of
non-target siRNA-expressing cells and of cells expressing the other siRNAs were compared by the Mann-Whitney U-test (P < 0.05, NT versus each siRNA).
siRNAs with inhibitory effects (A) and accelerating effects (B) on cell migration are shown. Positive and negative controls were measured together with 5
or 6 kinds of samples on one 24-well microplate in each experiment, therefore, the height of bars designated Pxn differs in the various histograms.
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for observations by light microscopy. Twenty-four hours
after transfection, we monitored the localization of eachprotein in NBT-L2b cells (Figure 3). As shown in
Figure 3A, four receptor-type kinases, Bmpr1a [10], Flt3
[11], Kit [12], and Tgfbr1 [13], were localized on the
Figure 2 siRNA-mediated knockdown of target mRNAs in NBT-L2b cells. siRNAs were introduced into NBT-L2b cells with the pVenus-N1
vector. After 48-h incubation, total RNA was isolated and quantitative PCR (qPCR) was performed with the QuantiTect SYBR Green RT-PCR Kit
(Qiagen). N = 4 replicates, average +/- SD *P < 0.05 in a comparison of control to each siRNA.
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Trib3 [17], Vrk3 [18], and Zfp512b [19] were detected in
the nucleus (Figure 3B). Ckmt1 [20] and Vapa [21] were
found in the mitochondria and on the endoplasmic
reticulum (ER), respectively, as described previously
(Figure 3C and D). Tfg was observed in transitional ER, as
described previously (Figure 3E) [22]. Figure 3F shows that
Ilk was localized to focal adhesion plaques, as reported
previously [23], and Dapk1 was distributed in a fibrillar
pattern, which suggested association with the cytoskeleton
(Figure 3G) [24]. Other gene products were abundant in
the cytoplasm, with noticeable concentration of some of
them along the margins of lamellipodia (Figure 3H).
Levels of expression of the identified genes in cells with
high and low invasive capacity
Nishi and coworkers isolated NBT-L2b cells, NBT-T1
cells and other cell lines from spontaneous variants of a
cell line derived from a rat bladder tumor, NBT-II [8].
They examined the invasive potential of these lines using
a Matrigel invasion chamber assay and they found that
NBT-L2b cells had high invasive potential while NBT-T1
cells had low invasive potential. Furthermore, NBT-L2b
cells migrated twice as fast as NBT-T1 cells on collagen-
coated dishes (data not shown). Nishi and coworkers
also reported that the level of expression of E-cadherin
(cadherin 1, Cdh1) in NBT-L2b cells was lower than that
in NBT-T1 cells, and that this difference might affect the
speed of cell migration [8]. To examine whether the
phenotypic difference between NBT-L2b and NBT-T1
cells reflects different levels of expression of the 32
selected genes, we performed qPCR (Figure 4). Expressionof the Cdh1 gene was used as a positive control. Levels of
expression of the Btk, Camk2b, Ksr1 and Prps2 genes were
somewhat higher (more than 1.4- to 2.0-fold difference)
and those of the Cdh1, Cdk13, Dapk1, Ilk, Kit, Map8ip,
Mob3c, Prkd1 and Zfp512b genes were lower (from
0.1- to 0.9-fold difference) in NBT-L2b cells than in
NBT-T1 cells.
Pathway analysis
The signal transduction pathway that mediates cell migra-
tion is not well understood. Protein-protein interaction
(PPI) databases are useful for analysis of the interactions
between molecules and their functional roles in signaling
networks. To determine the positions of the gene
products of interest within networks, we tried to confirm
the details of known signal-transduction pathways and
then to identify novel pathways involved in cell migration,
using the Genome Network Platform Viewer (URL:
http://genomenetwork.nig.ac.jp/public/sys/gnppub/Top.do).
We tried first to draw maps of pathways among the
proteins encoded by the newly identified genes, but
sufficient information was not available to allow us to
connect all the gene products on a single map. So we
turned our attention to phospholipase D1 (PLD1) and
phospholipase D2 (PLD2) because these enzymes interact
with many binding partners and are known to serve as
signaling hubs in cell migration [25]. We performed
PPI analysis with either PLD1 or PLD2 and each of
the identified kinases, hoping to generate a pathway that
would link them together. Maps showing the signaling
pathways between each PLD and individual proteins are
shown in Additional files 3 and 4. We found that EGFR,
Figure 3 Subcellular localization of target proteins in migrating cells. Each expression vector was introduced into NBT-L2b cells by transfection
on a collagen-coated glass dish. After 48 h, the localization of EGFP-fusion proteins was monitored by confocal microscopy. EGFP-fusion proteins were
seen in the plasma membrane (A), nucleus (B), mitochondria (C), ER (D), transitional ER (E), focal adhesions (F), cytoskeleton (G) and lamellipodia and
cytoplasm (H). Bar represents 10 μm.
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(orange circles, orange diamonds, and orange rounded
squares in Additional files 3 and 4). Focusing on the path-
ways on the various maps, we tried to generate a unified
pathway that would include the cellular location of each
gene product. The red lines in Figure 5 show the connec-
tions between each identified protein (red circles) and
PLDs (purple circles) that were obtained by PPI analysis
(Additional files 3 and 4). Finally, we put all the proteins
on this PPI map into the PPI database to identify
additional connections among the proteins shown in
Figure 5. These newly generated connections among
proteins were added to the PPI map as blue lines
(Figure 5). With 38 proteins newly added to the map
(blue circles), we found that interactions among 30 of
the 32 identified proteins (the exceptions being Cerkand Mob3c) were part of a single pathway (red circles)
(Figure 5). No data for Cerk and Mob3c are currently
available in the PPI database, and we were unable to place
these two proteins on our map. The signaling pathways
and subcellular localizations of the proteins on our map
revealed that the epidermal growth factor receptor (EGFR)
is the upstream regulator of the signal transduction
network, while Src and GRB2 seem to represent nodes
for control of respective downstream proteins required for
the many cellular events involved in migration.
Discussion
There are close to 40 anticancer drugs with specific
molecular targets on the market today (URL: http://scads.
jfcr.or.jp/db/table.html#table1). More than half of these
drugs target kinases, and novel inhibitors of kinases might
Figure 4 Levels of expression of the identified genes in minimally invasive (NBT-T1) and highly invasive (NBT-L2b) cells. Cells were
cultured for 10 h on a collagen-coated dish. Total RNA was isolated and quantitative PCR (qPCR) performed with a QuantiTect SYBR Green
RT-PCR Kit (Qiagen). Gray bars, NBT-T1; black bars, NBT-L2b *P < 0.05 in a comparison of NBT-T1 cells and NBT-L2b cells.
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migration might be involved in cancer metastasis, but the
molecular mechanisms that regulate cell migration
are poorly understood. We developed a novel TCM
technology as part of an effort to identify migration-related
genes and analyze gene networks related to cell migration.
In the first practical application of our method, we
screened a kinome siRNA library in a search for genes that
modulate cell migration.
We identified 53 potentially relevant siRNAs in our
first screening of a commercially available siRNA library
(Table 1 and Additional file 2). Two of these siRNAs,
one targeting Ilk and the other targeting Zfp512b, actually
enhanced cell migration (Table 1 and Additional file 2).
Zfp512b is a zinc finger protein and ILK is an
integrin-interacting protein kinase that has been identified
as a potential PDK2 (PI 3-kinase-dependent kinase-2)
since it is capable of phosphorylating PKB/Akt at Ser-473
and stimulating its activity [26].
In our second screening, we used a conventional
transfection method and acquisition of phase-contrast
images to exclude the possibility that fibronectin in the
transfection mix might inhibit cell migration, and
that continuous exposure to excitation light might be
phototoxic to cells. We subjected the 53 candidate genes
to the second screening (Figure 1) and confirmed the
knockdown of expression of individual genes by qPCR
(Figure 2). Among the initial 53 candidate genes, weidentified 32 genes from inspection of the knockdown
phenotype and level of expression. Thus, our TCM cell
chip proved to be a powerful tool for bulk screening of
genes. We performed qPCR four times to evaluate the
knockdown efficacy for each siRNA, and we found that
the Chka- and the Ksr-targeting siRNAs had only a
minimal inhibitory effect on gene expression (Figure 2).
Such suppression of expression of the Chka and Ksr genes
was, however, observed in three and two replicates,
respectively. Given that the expression of these genes in
NBT-L2b cells might fluctuate with the status of cells, we
included these two genes in our subsequent analysis. To
our surprise, we also identified two siRNA that accelerated
cell migration. These two siRNAs, targeting Ilk and
Zfp512b (Additional file 2), were also confirmed by qPCR
to knockdown their targets efficiently (Figure 2).
For convenience, we screened an existing kinome
siRNA library to identify genes required for cell migration.
To obtain more comprehensive information, we would
need to use a whole-genome siRNA library, and the
screening process would be very time-consuming. Therefore,
we used signal network analysis to obtain information
about connections that might have been missed in
the screening of the kinome siRNA library.
To determine the cellular localization of the proteins
encoded by the identified genes and to deduce their
potential roles in migrating cells, we cloned the cDNAs
of the 32 genes, as fusions with EGFP cDNA in plasmids
Figure 5 Hypothetical network relationships and subcellular localizations of the products of genes identified by screening in the
current study. A protein-protein interaction network was constructed using the experimental data from this study and data sets provided by the
Genome Network Platform Viewer. Red ovals, proteins identified by screening; blue ovals, proteins identified in PPI analysis with newly identified
proteins and PLDs; green ovals, proteins functioning as apparent signaling hubs; purple ovals, PLD1 and PLD2; red lines, connections between
PLDs and identified proteins; blue lines, connections between additional proteins, FA, Focal adhesions.
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mids. As noted above, six of the cDNAs were amplified
from a human cDNA library. Because we were interested
only in the localization of the products of the identified
genes in migrating cells and because it is likely that the
proteins are localized similarly in rat and human cells,
we postulated that the use of clones from a human
cDNA library would not invalidate our conclusions. The
individual EGFP fusion proteins were found at characteris-
tic locations in NBT-L2b cells that were migrating on
collagen-coated dishes (Figure 3). Our results suggested
that the products of each of the genes that we identified
might be involved in a specific event as a component of a
complex signaling-pathway network, as follows.
It has been reported that Chka, Kit, and Pik3ca
function in PI3K/AKT signaling [27-30] and that
Smad3, a transcription factor, is activated by Tgfbr1
and Trib3 [17,31]. Mapk8ip, Mapk8ip3 and Map4k4
participate in the regulation of JNK signaling [32-34].
JNK is involved in reorganization of the cytoskeleton via
phosphorylation of Spir, DCX, and other microtubule-
associated proteins [35]. Seven of the proteins, namely
Akap12, Bmpr1a, Chka, Ksr1, Trib3, Vrk3, and Zap70, are
involved in the ERK signaling pathway [18,30,36-40].
ERK1/2 is activated through the Ras-Raf-MEK1/2 cascade
via the binding of growth factors to cognate-receptor
tyrosine kinases at the plasma membrane. Activated ERK
can be translocated to the nucleus to regulate transcrip-
tion or it can be retained within the cytoplasm to regulate
a variety of activities, which include cell motility, changesin organelle structure, integrin signaling, and cytoskeletal
dynamics. For example, it has been proposed that
phosphorylation of paxillin, FAK, calpain, and MLCK by
ERK might regulate the dynamics of focal adhesion and
membrane protrusion, thereby influencing cell migration
[35]. Genes involved in ERK signaling form the largest
group within the 32 genes that we identified.
We measured the levels of expression of the identified
genes in highly-invasive (NBT-L2b) and minimally-invasive
(NBT-T1) cells to determine whether levels of expression
were correlated with invasive activity (Figure 4). Levels of
expression of Btk, Camk2b, Ksr1, and Prps2 were somewhat
higher than those of the other genes. Expression of these
four genes might be regulated at the transcriptional level,
but this hypothesis needs to be validated. Levels of expres-
sion of Cdh1, Cdk13, Dapk1, Ilk, Kit, Mapk8ip, Mob3c,
Prkd1, and Zfp512b were lower in NBT-L2b cells than in
NBT-T1 cells (Figure 4). Expression of many of the genes
might not be significantly higher in NBT-L2b cells than in
NBT-T1 cells, if post-transcriptional regulation, for example
by phosphorylation or genetic mutation, influenced the
activity or activation of gene products rather than the level
of gene expression.
We attempted to construct a signaling pathway using
the data obtained from our second screening in order to
enhance our understanding of the regulation of cell
migration. However, since we had only screened genes for
kinases and related proteins and also since the available
PPI data were limited, we were unable to generate a useful
map. Therefore, we chose PLDs as probes in an effort to
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The gene for PLD was identified as a migration gene in
Dictyostelium cells and it is required for the migration of
mammalian cells [41,42]. PLDs catalyze the hydrolysis of a
terminal diester bond in phosphatidylcholine, which is
abundant in the cell membrane, generating phosphatidic
acid (PA) and diacylglycerol [43]. The PA that is produced
by PLDs is an intracellular lipid mediator of many
biological functions and has been found to be associated
with numerous target proteins, such as Raf1, PI4P5 kinase,
and mTOR [44]. Furthermore, PLD1 and PLD2 are
known to bind to numerous proteins in cells and to form
large signaling hubs [25]. The shortest pathways between
PLDs and the identified proteins (with the exception
of Cerk and Mob3c, for which PPI information was
unavailable in the database) are shown in Additional files 3
and 4. Three proteins in particular, namely EGFR, GRB2
and Src, appear frequently on the PPI maps.
The interactions of 30 proteins were detected in one
network when 38 proteins were newly included, with
EGFR as the furthest upstream component of the pathway.
EGFR is a receptor tyrosine kinase that is overexpressed in
a variety of human epithelial malignancies, such as carcin-
omas of the lung, colon, ovary, bladder and head and neck
[45]. Moreover, enhanced expression of EGFR and the
subsequent increase in ERK and AKT signaling have been
implicated in the progression of prostate cancer [46].
Furthermore, impairment of endocytic down-regulation of
the activity of EGFR appears to contribute to the onco-
genic phenotype [47,48]. Thus, EGFR-ERK signaling might
be a major participant in the regulation of cell migration.
Furthermore, the frequent appearance of Grb2 and Src
during our PPI analysis indicated that these proteins might
also play a role as signal-transduction hubs to connect the
signal, via EGFR, from extracellular stimulation to key
proteins in various cellular events.
Cell migration is controlled by several intracellular
phenomena, which include membrane trafficking and
the endocytosis of EGFR [49,50]. Ligand-induced
endocytosis of EGFR has been reported to occur via
two pathways, namely, clathrin-dependent endocytosis
and caveolae-dependent endocytosis [49]. Although
the kinases that we identified do not play any known
role in the endocytosis of EGFR, the product of Cav1,
a gene newly identified by PPI analysis, is a major
participant in caveolae-dependent endocytosis [51].
It is possible that disruption of caveolae-dependent
endocytosis of EGFR regulates the migration of NBT-L2b
cell. Some of the proteins that we identified, such as
Btk, Camk2b, Kit, Map8ip, Mapk8ip3, Prkd1 and Vapa,
appear to regulate vesicular traffic according to the gene
ontology (URL: http://www.ncbi.nlm.nih.gov) and might
contribute to control of levels of expression of membrane
proteins.Six of the genes that we identified, namely, BTK, Chka,
Flt3, Kit, Pik3ca, and Tgfbr1 are the targets of anti-cancer
drugs in current clinical trials (http://www.cancer.gov/drug-
dictionary). Ksr1, which is moderately overexpressed in
highly invasive cells (Figure 4), activates ERK signaling and
is a target of the Nm23-H1 suppressor of metastasis [52].
Therefore, Ksr1 might be a candidate target for treatment
of malignant cancers. Other proteins on our map might
also be confirmed in future analysis to be candidate
targets for anti-cancer drugs.
Conclusions
Our selection method appears to provide a useful strategy
for approaching the details of cell migration. The EGFR
signaling pathway might be a major regulatory pathway in
cell migration. Cell migration can be disrupted by knocking
down individual genes, and such genes might become
candidate targets for anticancer drugs.
Methods
Materials
Fibronectin was purchased from Life Laboratory Com-
pany (Yamagata, Japan). Rhodamine-labeled fibronectin
was generated with an EZ-Label™ Rhodamine Protein
Labeling Kit (Pierce Biotechnology, Rockford, IL, USA)
according to the manufacturer’s protocol. Type B gelatin
from bovine skin was purchased from Sigma (St. Louis,
MO, USA). The pEGFP expression vector (BD Biosciences
Clontech, Tokyo, Japan) and the pVenus-N1 expression
vector (a gift from Dr. A. Miyawaki, RIKEN, Saitama,
Japan) were used as reporter plasmids. Non-targeted (NT)
siRNA and GFP-specific siRNA were obtained from
QIAGEN (Tokyo, Japan; GFP, green fluorescent protein).
Paxillin-specific (Pxn) siRNA (Rn_LOC360820_2_HP),
which suppresses the rat paxillin gene was obtained from
Qiagen. Since Pxn is a component of the adhesion
complex and is required for cell migration [53], we
chose expression of paxillin as a positive control in
our screening system. Non-coated glass slides (Matsunami
Glass Ind., Osaka, Japan) were used in this study. Rat
Kinase siRNA Set Version 1.0 (Qiagen) was used as the
kinome siRNA library.
Culture and transfection of cells
NBT-L2b and NBT-T1 cells were obtained from the
RIKEN Cell Bank (Tsukuba, Ibaraki, Japan) and grown
in MEM (Sigma, Tokyo, Japan), supplemented with
10% fetal bovine serum (MP BioChemicals, Cleveland,
OH, USA), non-essential amino acids (GIBCO-BRL,
Gaithersburg, MD), sodium pyruvate (GIBCO-BRL),
and a mixture of antibiotics, including penicillin and
streptomycin (GIBCO-BRL). HiPerFect Transfection
Reagent (Qiagen) was used for standard transfections
according to the manufacturer’s protocol.
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For isolation of total RNA, Isogen (Nippon Gene,
Tokyo, Japan) was added to siRNA-transfected cells,
non-transfected NBT-L2b cells, and NBT-T1 cells.
qPCR was performed with the QuantiTect® SYBR® Green
RT-PCR Kit (Qiagen) according to the manufacturer’s
protocol. The primers for qPCR (Qiagen) are shown in
Additional file 5.
Gene screening by TCM (first screening)
The basic preparation of the transfection microarray was
described in our previous reports [5,6]. In brief, 1 μg of
pEGFP-N1 vector and an siRNA (20 μM) were suspended
in serum-free Dulbecco’s Modified Eagle’s Medium
(GIBCO-BRL). After addition of Lipofectamine™ 2000
(Invitrogen, Tokyo, Japan), the mixture was incubated at
room temperature for 30 min. Rhodamine-labeled fibro-
nectin (4 mg/ml) and 0.1% gelatin were added, and the
resultant mixture was printed on collagen-coated glass
slides with a microarray printer (KCS-mini; KUBOTA
Comps., Osaka, Japan). Then, 2 × 105 cells were seeded
onto the printed glass slide and allowed to proliferate for
24 h. Fluorescence time-lapse images were recorded for
3 h at 10-min intervals with a Programmable Cellular
Image Tracer (Olympus, Tokyo, Japan). The speed of
migration of individual cells was analyzed with CellVoyager
(Yokogawa, Tokyo, Japan) and ImageJ software with a
manual tracking plug-in. The mean speeds of individual
cells that expressed a test or control siRNA (NT siRNA or
anti-Pxn siRNA) were used for statistical comparisons
by the Mann-Whitney U-test (statistical significance
recognized at P < 0.1, control versus each siRNA).
Screening genes by a motility assay (second screening)
siRNAs from the first screening, NT siRNA, or anti-Pxn
siRNA plus the pVenus-N1 vector were introduced into
NBT-L2b cells by the conventional transfection method
described above. After 38 h, siRNA-transfected cells
(3 × 104 cells) were diluted in 1 ml of DMEM/F12 Ham’s
medium (Sigma), supplemented with 10% fetal bovine
serum and a mixture of antibiotics, and seeded in wells
of a non-treated 24-well microplate (Asahi Glass., Ltd,
Tokyo, Japan) that had been coated with a 0.001% solution
(w/v) of type I collagen (Research Institute for Functional
Peptides, Yamagata, Japan). After a 3-h incubation, the
medium was replaced with 1 ml of fresh DMEM/F12
Ham’s medium. The microplate was placed in a
Programmable Cellular Image Tracer and incubated for at
least 3 h. Fluorescence and phase-contrast snapshot
images were captured and phase-contrast time-lapse im-
ages were recorded for 6 h at 5-min intervals with the
Image Tracer, and analyzed with the ImageJ software. The
migration speeds of cells that had been transfected with
NT siRNA and the test siRNAs were compared by theMann-Whitney U-test (statistical significance recognized
at P < 0.05, NT versus each siRNA).
Subcellular localization of gene products
Full-length cDNAs of genes identified in the second
screening were cloned from cDNA libraries derived from
NBT-L2b cells or from the human HeLa and HL60 cell
lines. Details of expression vectors and cloned genes are
shown in Additional file 6. The expression vectors were
introduced into NBT-L2b cells with HiPerFect according
to the manufacturer’s protocol. Transfected cells were
incubated for at least 24 h and observed with a confocal
laser scanning microscope (Yokogawa, Tokyo, Japan).
Pathway analysis
We used PPI network data from the Genome Network
Platform database (GNP, http://genomenetwork.nig.ac.
jp/public/sys/gnppub/Top.do) to map the signaling path-
ways that connected the proteins that we had identified
as migration-related. We entered the identified proteins
and PLDs into the Path Search of the PPI database.
From maps of signal pathways for each PLD and an
identified protein, we generated integrated signal pathways.
In addition, the intracellular localization of the identified
proteins was added to the final map.
Additional files
Additional file 1: Schematic representation of a TCM-based cell
chip for monitoring cell migration. The transfection mixture, consisting
of Lipofectamine™ 2000, the pEGFP-N1 expression vector, siRNA,
rhodamine-labeled fibronectin, and gelatin, was printed as a 4 × 12
grid on the surface of a collagen-coated glass slide by a high-precision
inkjet microarrayer (KUBOTA Comps., Osaka, Japan). Red signals from
rhodamine-labeled fibronectin identified the spots of the transfection
mixture on the slide. For analysis, NBT-L2b cells were seeded and
incubated on the printed chip for 24 h. Cells transfected with siRNA
were recognized by the fluorescence of EGFP.
Additional file 2: Effects of siRNAs in the first screening. NBT-L2b
cells were seeded onto a printed glass slide and fluorescence time-lapse
images were recorded for 3 h at 10-min intervals with a Programmable
Cellular Image Tracer (OLYMPUS, Tokyo, Japan), and analyzed by ImageJ
software with a manual tracking plug-in. siRNAs are indicated by their
target genes. Dark gray bars, non-target siRNA-transfected cells; light
gray bars, anti-paxillin siRNA-transfected cells; black bars, cells transfected
with specific siRNAs. **P < 0.05 in a comparison of control to each siRNA.
*P < 0.1 in a comparison of control to each siRNA.
Additional file 3: Protein-protein interactions for products of newly
identified genes and PLD1. Red squares, PLD1 and products of newly
identified genes; orange circles, EGFR; orange rounded squares, Src; and
orange diamonds, GRB2.
Additional file 4: Protein-protein interactions for products of newly
identified genes and PLD2. Red squares, PLD2 and products of newly
identified genes; orange circles, EGFR; orange rounded squares, Src; and
orange diamonds, GRB2.
Additional file 5: siRNAs identified in the second screening, their
target genes, and the corresponding primers for qPCR.
Additional file 6: List of cloned genes and their expression vectors.
All cDNA fragments were cloned into the multiple cloning sites of
pEGFP-N1 or vectors in the pEGFP-C series.
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